Galapagos competitive analysis

Loading summary...

Explore Galapagos's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 20, 2023Pharmaceutical Compositions Comprising A Jak Inhibitor3
Mar 1, 20175-Phenyl-[1,2,4]Triazolo[1,5-A]Pyridin-2-Yl Carboxamides As Jak Inhibitors1

Latest publications and patents of Galapagos New

Explore the latest publications and patents granted to Galapagos, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Galapagos

Dec 20, 2023Pharmaceutical Compositions Comprising A Jak InhibitorGranted And Under Opposition
Mar 1, 20175-Phenyl-[1,2,4]Triazolo[1,5-A]Pyridin-2-Yl Carboxamides As Jak InhibitorsOpposition Rejected

Latest PTAB cases involving Galapagos

Discover the latest PTAB cases involving Galapagos, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Galapagos with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GALAPAGOS - 4 - -
GENERICS UK214 - - -